RecruitingNCT07022704

Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial

The Influence of Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial: a Prospective Observational Study


Sponsor

Cairo University

Enrollment

35 participants

Start Date

Jun 22, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Researchers aim to evaluate the impact of doxapram administration on diaphragmatic excursion in chronic obstructive pulmonary disease (COPD) patients undergoing spontaneous breathing trial


Eligibility

Min Age: 20 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a breathing stimulant drug called doxapram can help the diaphragm (the main breathing muscle) work better in patients with severe chronic lung disease (COPD) who are on a breathing machine and being weaned off it. **You may be eligible if...** - You have moderate to severe COPD - You are currently on a ventilator (breathing machine) - You are in a spontaneous breathing trial — a test to see if you can breathe on your own **You may NOT be eligible if...** - You have refused to participate - You have an allergy to doxapram - You have a neuromuscular disorder (a condition affecting your muscles or nerves) - Doctors are unable to evaluate your diaphragm with ultrasound Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDoxapram

Doxapram will be given as 1.5 mg/kg will be given 10 minutes after the initiation of SBT


Locations(1)

Cairo University

Cairo, Cairo Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07022704


Related Trials